Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ingevity Corporation Common Stock (NY: NGVT )

43.95 +0.57 (+1.31%)
Official Closing Price Updated: 4:10 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ingevity Corporation Common Stock

< Previous 1 2 3 Next >
Earnings Scheduled For February 18, 2025
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Ingevity
Via Benzinga
A Look Ahead: Ingevity's Earnings Forecast
Via Benzinga
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company. 
Via Benzinga
Topics Government
Exposures Political
Ingevity Explores Strategic Options For Performance Chemicals Segment To Strengthen Portfolio, Projects FY24 Revenue At $1.40 Billion
Ingevity Corp (NYSE: NGVT) is reviewing options for its Performance Chemicals Industrial Specialties segment, aiming to streamline and improve earnings. Preliminary FY24 results also announced. 
Via Benzinga
Nasdaq Moves Lower; Levi Strauss Shares Slide
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
Via Benzinga
Exposures Fossil Fuels
Unveiling 4 Analyst Insights On Ingevity
Via Benzinga
Assessing Ingevity: Insights From 5 Financial Analysts
Via Benzinga
Ingevity Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
NGVT Stock Earnings: Ingevity Misses EPS, Misses Revenue for Q2 2024
NGVT stock results show that Ingevity missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
NGVT Stock Earnings: Ingevity Beats EPS, Beats Revenue for Q1 2024
NGVT stock results show that Ingevity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Recap: Ingevity Q4 Earnings
Via Benzinga
Stocks Muted As Oil Prices Take A Breather
The Dow Jones Industrial Average, S&P 500 Index, and Nasdaq Composite are flat this afternoon, shrugging off strong premarket gains. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
Ingevity's Earnings Outlook
Via Benzinga
ZK International Meets Nasdaq Standards; Overbought Trends In Materials Sector; Galiano Gold Updates On Asanko
Stainless steel and carbon steel engineer and manufacturer ZK International Group (NASDAQ: ZKIN) has regained compliance with Nasdaq over a bid price deficiency after the company's closing bid price... 
Via Benzinga
Earnings Outlook For Ingevity
Via Benzinga
Ingevity In For A Bumpy Ride In The CTO Market, Analyst Downgrades Rating
BMO Capital Market analyst John P. 
Via Benzinga
Analyst Expectations for Ingevity's Future
Via Benzinga
Top 4 Materials Stocks That May Collapse This Quarter
As of Dec. 26, 2023, four stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Overview Of Value Stocks In The Basic Materials Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
Via Benzinga
Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.